Jin Yang Pharmaceutical Co. Ltd (KQ:007370) — Stock Price

₩3980.00 KRW
▲ 1.40% today

Jin Yang Pharmaceutical Co. Ltd (KQ:007370) is currently trading at ₩3980.00 KRW, up 1.40% today. Over the past 52 weeks, shares have ranged between ₩3440.00 and ₩6060.00. This page tracks Jin Yang Pharmaceutical Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Jin Yang Pharmaceutical Co. Ltd (007370) market capitalisation.

Jin Yang Pharmaceutical Co. Ltd (007370) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Jin Yang Pharmaceutical Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Jin Yang Pharmaceutical Co. Ltd Income Statement — Revenue, Profit & Earnings by Year

Jin Yang Pharmaceutical Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ₩120.69 Billion ₩113.33 Billion ₩94.11 Billion ₩76.26 Billion ₩62.84 Billion
Cost of Revenue ₩42.54 Billion ₩43.45 Billion ₩36.65 Billion ₩30.61 Billion ₩28.86 Billion
Gross Profit ₩78.15 Billion ₩69.88 Billion ₩57.46 Billion ₩45.65 Billion ₩33.98 Billion
Research & Development — — — — —
SG&A ₩54.57 Billion ₩57.81 Billion ₩48.02 Billion ₩34.17 Billion ₩26.73 Billion
Total Operating Expenses ₩118.16 Billion ₩101.62 Billion ₩85.03 Billion ₩65.13 Billion ₩55.88 Billion
Operating Income ₩2.53 Billion ₩11.43 Billion ₩9.30 Billion ₩11.46 Billion ₩6.96 Billion
EBITDA — — — — —
EBIT — — — ₩11.14 Billion ₩6.96 Billion
Interest Expense ₩2.29 Billion ₩1.86 Billion ₩1.37 Billion ₩1.29 Billion ₩208.28 Million
Income Before Tax ₩28.10 Billion ₩37.05 Billion ₩12.58 Billion ₩14.54 Billion ₩12.13 Billion
Income Tax Expense — — — ₩2.23 Billion ₩2.59 Billion
Net Income ₩22.29 Billion ₩29.69 Billion ₩12.66 Billion ₩12.31 Billion ₩9.54 Billion

Jin Yang Pharmaceutical Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Jin Yang Pharmaceutical Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ₩267.81 Billion ₩227.57 Billion ₩119.91 Billion ₩114.44 Billion ₩98.50 Billion
Total Current Assets ₩46.02 Billion ₩43.35 Billion ₩48.03 Billion ₩46.33 Billion ₩41.00 Billion
Cash & Equivalents — ₩1.78 Billion ₩5.12 Billion ₩753.56 Million ₩11.72 Billion
Short-term Investments ₩3.68 Billion ₩233.78 Million ₩3.48 Billion ₩9.74 Billion ₩3.16 Billion
Net Receivables ₩23.06 Billion ₩26.10 Billion ₩21.71 Billion ₩19.88 Billion ₩16.67 Billion
Inventory ₩15.62 Billion ₩14.62 Billion ₩17.35 Billion ₩15.42 Billion ₩9.06 Billion
Property, Plant & Equipment — ₩43.49 Billion ₩44.14 Billion ₩43.79 Billion ₩39.36 Billion
Goodwill — — — — —
Total Liabilities ₩107.95 Billion ₩107.70 Billion ₩30.32 Billion ₩36.87 Billion ₩33.18 Billion
Total Current Liabilities ₩88.08 Billion ₩19.79 Billion ₩24.51 Billion ₩30.94 Billion ₩27.14 Billion
Long-term Debt — ₩75.30 Billion — — —
Net Debt ₩74.22 Billion ₩77.50 Billion ₩2.41 Billion ₩9.16 Billion —
Total Stockholder Equity ₩159.86 Billion ₩119.88 Billion ₩89.58 Billion ₩77.58 Billion ₩65.32 Billion
Retained Earnings ₩109.57 Billion ₩88.67 Billion ₩62.15 Billion ₩51.88 Billion ₩40.63 Billion

Jin Yang Pharmaceutical Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Jin Yang Pharmaceutical Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ₩1.46 Billion ₩12.79 Billion ₩8.53 Billion ₩7.45 Billion ₩1.97 Billion
Capital Expenditures ₩3.67 Billion ₩947.22 Million ₩1.53 Billion ₩3.22 Billion ₩2.52 Billion
Free Cash Flow ₩-2.21 Billion ₩11.85 Billion ₩7.00 Billion ₩2.81 Billion ₩-752.94 Million
Investing Cash Flow — ₩-86.28 Billion ₩3.24 Billion ₩-12.83 Billion ₩-4.28 Billion
Financing Cash Flow — ₩70.15 Billion ₩-7.40 Billion ₩-5.58 Billion ₩8.85 Billion
Dividends Paid ₩-1.71 Billion ₩1.62 Billion ₩1.62 Billion ₩1.12 Billion ₩1.12 Billion
Stock-Based Compensation — — — — —
Depreciation ₩2.41 Billion ₩1.52 Billion ₩2.38 Billion ₩2.29 Billion ₩2.15 Billion
Change in Cash ₩423.93 Million ₩-3.34 Billion ₩4.36 Billion ₩-10.97 Billion ₩6.54 Billion

Jin Yang Pharmaceutical Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Jin Yang Pharmaceutical Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 158.90 — —
Dec 31, 2025 1367.28 — —
Sep 30, 2025 -80.20 — —
Jun 30, 2025 142.28 — —
Mar 31, 2025 192.89 — —
Dec 31, 2024 222.92 — —
Sep 30, 2024 1592.00 — —
Jun 30, 2024 100.93 — —